This is a prospective cohort study of persons tested for latent tuberculosis infection at either high risk for exposure to Mycobacterium tuberculosis or high risk for progression to tuberculosis disease. The study will assess the relative performance and cost of three diagnostic tests for latent tuberculosis infection (tuberculin skin test, QuantiFERON-TB Gold In-Tube, and T-SPOT.TB) and will examine the rates of positive results among the cohort. This study will also determine the risk and rate of progression to active TB disease, overall and by the results of the three tests.
Study Type
OBSERVATIONAL
Enrollment
21,334
Maricopa County Department of Public Health
Phoenix, Arizona, United States
California Department of Public Health
Richmond, California, United States
Denver Health and Hospitals Authority
Denver, Colorado, United States
University of Florida Board of Trustees
Gainesville, Florida, United States
Emory University
Atlanta, Georgia, United States
Hawaii Department of Health
Honolulu, Hawaii, United States
Maryland Department of Public Health
Baltimore, Maryland, United States
Duke University
Durham, North Carolina, United States
University of North Texas Health Science Center
Fort Worth, Texas, United States
Public Health Seattle-King County
Seattle, Washington, United States
Latent tuberculosis infection
Time frame: 3 days
Tuberculosis disease at 6 months
Time frame: 6 months
Tuberculosis disease at 12 months
Time frame: 12 months
Tuberculosis disease at 18 months
Time frame: 18 months
Tuberculosis disease at 24 months
Time frame: 24 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.